{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:32:50Z","timestamp":1772706770631,"version":"3.50.1"},"reference-count":44,"publisher":"Termedia Sp. z.o.o.","issue":"2","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cent Eur J Immunol"],"abstract":"<jats:sec>\n                    <jats:title>Aim of the study<\/jats:title>\n                    <jats:p>Assessment of the peripheral blood picture and aminotransferase activity in children with newly diagnosed Graves\u2019 disease (GD) at baseline and 4-6 weeks after the initiation of antithyroid drug (ATD) therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>Data of 59 children were assessed retrospectively. Baseline analysis included concentrations of thyroid-stimulating hormone (TSH), free triiodothyronine (fT3), free thyroxine (fT4), TSH receptor antibodies (TSH-R Ab), complete blood cell count (CBC), aspartate (AST) and alanine aminotransferase (ALT) activity. Reassessment of CBC and aminotransferase activity was performed 4-6 weeks after the initiation of ATD therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Significant decreases in the neutrophil count, MCV, haemoglobin (Hgb), red blood cell (RBC) count, white blood cell (WBC) count and platelet (PLT) count were found in 37.3%, 32.2%, 22%, 13.6%, 8.5% and 5% of untreated patients, respectively. Increased baseline ALT and AST activity was observed in 44% and 32.2% of children, respectively. Initiation of ATD therapy led to significant changes in Hgb, RBC and PLT count, RDW and ALT activity. Negative associations between TSH-R Ab, TSH and MCV were found. ALT and AST activity were negatively related to baseline TSH levels. ALT activity was also associated with baseline fT4 and fT3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The incidence of haematopoiesis and liver abnormalities in GD children seems to be similar to that reported in adult patients. The most common alterations are changes in neutrophil count, RBC parameters and ALT activity. The initiation of ATD therapy usually leads to significant improvement in those parameters.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5114\/ceji.2019.87063","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T08:34:50Z","timestamp":1566290090000},"page":"132-137","source":"Crossref","is-referenced-by-count":5,"title":["Peripheral blood picture and aminotransferase activity in children with newly diagnosed Graves\u2019 disease at baseline and after the initiation of antithyroid drug therapy"],"prefix":"10.5114","volume":"44","author":[{"given":"Dorota","family":"Artemniak-Wojtowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelina","family":"Witkowska-S\u0119dek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ada","family":"Borowiec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Pyr\u017cak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3061","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"key":"ref-1548371","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/eje.0.1300565","article-title":"Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study","volume":"130","author":"Lavard L","year":"1994","unstructured":"Lavard L, Ranl\u00f8v I, Perrild H, et al. (1994). Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study. Eur J Endocrinol. 130: 565-568.","journal-title":"Eur J Endocrinol"},{"key":"ref-1548372","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association Guideline for the Management of Graves\u2019 Hyperthyroidism","volume":"7","author":"Kahaly GJ","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, et al. (2018). 2018 European Thyroid Association Guideline for the Management of Graves\u2019 Hyperthyroidism. Eur Thyroid J. 7: 167-186.","journal-title":"Eur Thyroid J"},{"key":"ref-1548373","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1744-313X.2009.00830.x","article-title":"Autoimmune thyroid diseases: genetic susceptibility of thyroid-specific genes and thyroid autoantigens contributions","volume":"36","author":"Hadj-Kacem H1","year":"2009","unstructured":"Hadj-Kacem H1, Rebuffat S, Mnif-F\u00e9ki M, et al. (2009). Autoimmune thyroid diseases: genetic susceptibility of thyroid-specific genes and thyroid autoantigens contributions. Int J Immunogenet. 36: 85-96.","journal-title":"Int J Immunogenet"},{"key":"ref-1548374","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/thy.1998.8.727","article-title":"What is the evidence of genetic factors in the etiology of Graves\u2019 disease? A brief review","volume":"8","author":"Brix TH","year":"1998","unstructured":"Brix TH, Kyvik KO, Heged\u00fcs L. (1998). What is the evidence of genetic factors in the etiology of Graves\u2019 disease? A brief review. Thyroid. 8: 727-734.","journal-title":"Thyroid"},{"key":"ref-1548375","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2010.01.013","article-title":"Genetics of thyroid autoimmunity and the role of the TSHR","volume":"322","author":"Brand OJ","year":"2010","unstructured":"Brand OJ, Gough SC. (2010). Genetics of thyroid autoimmunity and the role of the TSHR. Mol Cell Endocrinol. 322: 135-143.","journal-title":"Mol Cell Endocrinol"},{"key":"ref-1548376","first-page":"661","article-title":"Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study","volume":"160","author":"Brix TH","year":"2000","unstructured":"Brix TH, Hansen PS, Kyvik KO, Hegedus L. (2000). Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study. Arch Intern Med. 160: 661-666.","journal-title":"Arch Intern Med"},{"key":"ref-1548377","volume-title":"Endotext [Internet]","author":"DeGroot LJ","unstructured":"DeGroot LJ, De Groot LJ, Chrousos G, Dungan K, et al. (). Endotext [Internet].  MDText.com Inc, South Dartmouth (MA).  https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK285548\/. Available from: ."},{"key":"ref-1548378","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fimmu.2017.00521","article-title":"Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases","volume":"8","author":"Fr\u00f6hlich E","year":"2017","unstructured":"Fr\u00f6hlich E, Wahl R. (2017). Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 8: 521.","journal-title":"Front Immunol"},{"key":"ref-1548379","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","article-title":"Graves\u2019 disease","volume":"343","author":"Weetman AP","year":"2000","unstructured":"Weetman AP. (2000). Graves\u2019 disease. N Engl J Med. 343: 1236-1248.","journal-title":"N Engl J Med"},{"key":"ref-1548380","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/qjmed\/95.9.559","article-title":"The relationship between the thyroid gland and the liver","volume":"95","author":"Malik R","year":"2002","unstructured":"Malik R, Hodgson H. (2002). The relationship between the thyroid gland and the liver. QJM. 95: 559-569.","journal-title":"QJM"},{"key":"ref-1548381","first-page":"73","article-title":"Effect of thyroid dysfunction on blood cell count and red blood cell indice","volume":"3","author":"Dorgalaleh A","year":"2013","unstructured":"Dorgalaleh A, Mahmoodi M, Varmaghani B, et al. (2013). Effect of thyroid dysfunction on blood cell count and red blood cell indice. Iran J Ped Hematol Oncol. 3: 73-77.","journal-title":"Iran J Ped Hematol Oncol"},{"key":"ref-1548382","doi-asserted-by":"crossref","first-page":"325092","DOI":"10.5402\/2012\/325092","article-title":"Hepatic dysfunction in hospitalized patients with acute thyrotoxicosis: a decade of experience","volume":"2012","author":"Elias RM","year":"2012","unstructured":"Elias RM, Dean DS, Barsness GW. (2012). Hepatic dysfunction in hospitalized patients with acute thyrotoxicosis: a decade of experience. ISRN Endocrinol. 2012: 325092.","journal-title":"ISRN Endocrinol"},{"key":"ref-1548383","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1210\/jc.2003-030185","article-title":"Antithyroid drugs in the management of patients with Graves\u2019 disease: an evidence-based approach to therapeutic controversies","volume":"88","author":"Cooper DS","year":"2003","unstructured":"Cooper DS. (2003). Antithyroid drugs in the management of patients with Graves\u2019 disease: an evidence-based approach to therapeutic controversies. J Clin Endocrinol Metab. 88: 3474-3481.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref-1548384","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper DS","year":"2005","unstructured":"Cooper DS. (2005). Antithyroid drugs. N Engl J Med. 352: 905-917.","journal-title":"N Engl J Med"},{"key":"ref-1548385","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJMc0809750","article-title":"Ending propylthiouracil-induced liver failure in children","volume":"360","author":"Rivkees SA","year":"2009","unstructured":"Rivkees SA, Mattison DR. (2009). Ending propylthiouracil-induced liver failure in children. N Engl J Med. 360: 1574-1575.","journal-title":"N Engl J Med"},{"key":"ref-1548386","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1210\/jc.2009-2546","article-title":"Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children","volume":"95","author":"Rivkees SA","year":"2010","unstructured":"Rivkees SA, Szarfman A. (2010). Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab. 95: 3260-3267.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref-1548387","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","article-title":"Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves\u2019 disease","volume":"92","author":"Nakamura H","year":"2007","unstructured":"Nakamura H, Noh JY, Itoh K, et al. (2007). Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves\u2019 disease. J Clin Endocrinol Metab. 92: 2157-2162.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref-1548388","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2257.2002.00460.x","article-title":"Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of literature","volume":"24","author":"Shaw B","year":"2002","unstructured":"Shaw B, Mehta AB. (2002). Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of literature. Clin Lab Haematol. 24: 385-387.","journal-title":"Clin Lab Haematol"},{"key":"ref-1548389","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1530\/EJE-09-0875","article-title":"Clinical relevance of thyroid dysfunction in human haematopoiesis: biochemical and molecular studies","volume":"162","author":"Kawa MP","year":"2010","unstructured":"Kawa MP, Grymu\u0142a K, Paczkowska E, et al. (2010). Clinical relevance of thyroid dysfunction in human haematopoiesis: biochemical and molecular studies. Eur J Endocrinol. 162: 295-305.","journal-title":"Eur J Endocrinol"},{"key":"ref-1548390","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.1977.tb06833.x","article-title":"Thyroid hormones stimulate erythropoiesis in vitro","volume":"37","author":"Golde DW","year":"1977","unstructured":"Golde DW, Bersch N, Chopra IJ. (1977). Thyroid hormones stimulate erythropoiesis in vitro. Br J Haematol. 37: 173-177.","journal-title":"Br J Haematol"},{"key":"ref-1548391","doi-asserted-by":"crossref","first-page":"194542","DOI":"10.1155\/2013\/194542","article-title":"Graves\u2019 disease causing pancytopenia and autoimmune hemolytic anemia at different time intervals: a case report and a review of the literature","volume":"2013","author":"Naji P","year":"2013","unstructured":"Naji P, Kumar G, Dewani S, et al. (2013). Graves\u2019 disease causing pancytopenia and autoimmune hemolytic anemia at different time intervals: a case report and a review of the literature. Case Rep Med. 2013: 194542.","journal-title":"Case Rep Med"},{"key":"ref-1548392","doi-asserted-by":"crossref","first-page":"1179547618781090","DOI":"10.1177\/1179547618781090","article-title":"Graves\u2019 disease causing pancytopenia: case report and literature review","volume":"11","author":"Pincet L","year":"2018","unstructured":"Pincet L, Gorostidi F. (2018). Graves\u2019 disease causing pancytopenia: case report and literature review. Clin Med Insights Case Rep. 11: 1179547618781090.","journal-title":"Clin Med Insights Case Rep"},{"key":"ref-1548393","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/pgmj.64.756.735","article-title":"The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis","volume":"64","author":"Ford HC","year":"1988","unstructured":"Ford HC, Carter JM. (1988). The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis. Postgrad Med J. 64: 735-742.","journal-title":"Postgrad Med J"},{"key":"ref-1548394","doi-asserted-by":"crossref","first-page":"17","DOI":"10.18388\/abp.2017_2321","article-title":"The mutual cooperation of blood platelets and lymphocytes in the development of autoimmune thyroid diseases","volume":"65","author":"Tomczy\u0144ska M","year":"2018","unstructured":"Tomczy\u0144ska M, Saluk-Bijak J. (2018). The mutual cooperation of blood platelets and lymphocytes in the development of autoimmune thyroid diseases. Acta Biochim Pol. 65: 17-24.","journal-title":"Acta Biochim Pol"},{"key":"ref-1548395","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00004836-199912000-00004","article-title":"Thyroid storm presenting with liver failure","volume":"29","author":"Choudhary AM","year":"1999","unstructured":"Choudhary AM, Roberts I. (1999). Thyroid storm presenting with liver failure. J Clin Gastroenterol. 29: 318-321.","journal-title":"J Clin Gastroenterol"},{"key":"ref-1548396","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3923\/jbs.2013.665.678","article-title":"Liver functional behaviour during thyrotoxicosis: a review","volume":"13","author":"Mansourian AR","year":"2013","unstructured":"Mansourian AR. (2013). Liver functional behaviour during thyrotoxicosis: a review. J Biol Sci. 13: 665-678.","journal-title":"J Biol Sci"},{"key":"ref-1548397","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/cen.13312","article-title":"Incidence of abnormal liver biochemical tests in hyperthyroidism","volume":"86","author":"Lin TY","year":"2017","unstructured":"Lin TY, Shekar AO, Li N, et al. (2017). Incidence of abnormal liver biochemical tests in hyperthyroidism. Clin Endocrinol (Oxf). 86: 755-759.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref-1548398","first-page":"1614","article-title":"Abnormalities in measures of liver function and injury in thyroid disorders","volume":"44","author":"Bayraktar M","year":"1997","unstructured":"Bayraktar M, Van Thiel DH. (1997). Abnormalities in measures of liver function and injury in thyroid disorders. Hepatogastroenterology. 44: 1614-1618.","journal-title":"Hepatogastroenterology"},{"key":"ref-1548399","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/milmed\/143.8.548","article-title":"Abnormalities of liver function tests in thyrotoxicosis","volume":"143","author":"Thompson P","year":"1978","unstructured":"Thompson P, Strum D, Boehm T, et al. (1978). Abnormalities of liver function tests in thyrotoxicosis. Military Medicine. 143: 548-551.","journal-title":"Military Medicine"},{"key":"ref-1548400","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/000992289303200105","article-title":"Propylthiouracil hepatotoxicity: a review and case presentation","volume":"32","author":"Levy M","year":"1993","unstructured":"Levy M. (1993). Propylthiouracil hepatotoxicity: a review and case presentation. Clin Pediatr (Phila). 32: 25-29.","journal-title":"Clin Pediatr (Phila)"},{"key":"ref-1548401","first-page":"300","article-title":"[Changes in the blood picture in hyperthyroidism]","volume":"44","author":"Hambsch K","year":"1989","unstructured":"Hambsch K, Herrmann F, Fischer H, et al. (1989). [Changes in the blood picture in hyperthyroidism]. Z Gesamte Inn Med. 44: 300-306.","journal-title":"Z Gesamte Inn Med"},{"key":"ref-1548402","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0889-8588(18)30675-0","article-title":"Hematologic abnormalities in patients with endocrine and metabolic disorders","volume":"1","author":"Orwoll ES","year":"1987","unstructured":"Orwoll ES, Orwoll RL. (1987). Hematologic abnormalities in patients with endocrine and metabolic disorders. Hematol Oncol Clin North Am. 1: 261-279.","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref-1548403","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2265.2008.03382.x","article-title":"Characterization of anemia associated with Graves\u2019 disease","volume":"70","author":"Gianoukakis AG","year":"2009","unstructured":"Gianoukakis AG, Leigh MJ, Richards P, et al. (2009). Characterization of anemia associated with Graves\u2019 disease. Clin Endocrinol (Oxf). 70: 781-787.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref-1548404","first-page":"143","article-title":"The peripheral blood picture in thyrotoxicosis","volume":"93","author":"Reddy J","year":"1981","unstructured":"Reddy J, Brownlie BE, Heaton DC, et al. (1981). The peripheral blood picture in thyrotoxicosis. N Z Med J. 93: 143-145.","journal-title":"N Z Med J"},{"key":"ref-1548405","first-page":"1476","article-title":"Role of red blood cell distribution width (rdw) in thyroid dysfunction","volume":"3","author":"Geetha JP","year":"2012","unstructured":"Geetha JP, Srikrishna R. (2012). Role of red blood cell distribution width (rdw) in thyroid dysfunction. Int J Biol Med Res. 3: 1476-1478.","journal-title":"Int J Biol Med Res"},{"key":"ref-1548406","first-page":"216","article-title":"Peripheral blood leucocytes in thyrotoxicosis (Graves\u2019 disease) as studied by conventional light microscopy","volume":"27","author":"Irvine WJ","year":"1977","unstructured":"Irvine WJ, Wu FC, Urbaniak SJ, Toolis F. (1977). Peripheral blood leucocytes in thyrotoxicosis (Graves\u2019 disease) as studied by conventional light microscopy. Clin Exp Immunol. 27: 216-221.","journal-title":"Clin Exp Immunol"},{"key":"ref-1548407","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00007611-198303000-00017","article-title":"Effect of therapy on the neutropenia of hyperthyroidism","volume":"76","author":"Eakin DL","year":"1983","unstructured":"Eakin DL, Peake RL, Weiss GB. (1983). Effect of therapy on the neutropenia of hyperthyroidism. South Med J. 76: 335-337.","journal-title":"South Med J"},{"key":"ref-1548408","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000207396","article-title":"Thrombocytopenia in Graves\u2019 disease: effect of T3 on platelet kinetics","volume":"63","author":"Kurata Y","year":"1980","unstructured":"Kurata Y, Nishioeda Y, Tsubakio T, Kitani T. (1980). Thrombocytopenia in Graves\u2019 disease: effect of T3 on platelet kinetics. Acta Haematol. 63: 185-190.","journal-title":"Acta Haematol"},{"key":"ref-1548409","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004836-199204000-00010","article-title":"Hyperthyroidism and hepatic dysfunction. A case series analysis","volume":"14","author":"Fong TL","year":"1992","unstructured":"Fong TL, McHutchinson JG, Reynolds TB. (1992). Hyperthyroidism and hepatic dysfunction. A case series analysis. J Clin Gastroenterol. 14: 240-244.","journal-title":"J Clin Gastroenterol"},{"key":"ref-1548410","first-page":"1727","article-title":"Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned?","volume":"82","author":"Williams KV","year":"1997","unstructured":"Williams KV, Nayak S, Becker D, et al. (1997). Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned?. J Clin Endocrinol Metab. 82: 1727-1733.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref-1548411","first-page":"5","article-title":"Risk factors of hepatic dysfunction in patients with Graves\u2019 hyperthyroidism and the efficacy of 131iodine treatment","volume":"96","author":"Wang R","year":"2017","unstructured":"Wang R, Tan J, Zhang G, et al. (2017). Risk factors of hepatic dysfunction in patients with Graves\u2019 hyperthyroidism and the efficacy of 131iodine treatment. Medicine. 96: 5.","journal-title":"Medicine"},{"key":"ref-1548412","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4158\/EP.6.5.367","article-title":"Abnormal results of liver function tests in patients with Graves\u2019 disease","volume":"6","author":"Biscoveanu M","year":"2000","unstructured":"Biscoveanu M, Hasinski S. (2000). Abnormal results of liver function tests in patients with Graves\u2019 disease. Endocr Pract. 6: 367-369.","journal-title":"Endocr Pract"},{"key":"ref-1548413","first-page":"75","article-title":"Evaluate the liver function in hyperthyroidism patients","volume":"5","author":"Madani SH","year":"2014","unstructured":"Madani SH, Far ZR, Jalilian N, et al. (2014). Evaluate the liver function in hyperthyroidism patients. J Paramed Sci. 5: 75-78.","journal-title":"J Paramed Sci"},{"key":"ref-1548414","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.2007.03068.x","article-title":"Association between serum TSH, free T4 and serum liver enzyme activities in large cohort of unselected outpatients","volume":"68","author":"Targher G","year":"2008","unstructured":"Targher G, Montagnana M, Salvagno G, et al. (2008). Association between serum TSH, free T4 and serum liver enzyme activities in large cohort of unselected outpatients. Clin Endocrinol (Oxf). 68: 481-484.","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Central European Journal of Immunology"],"original-title":[],"link":[{"URL":"https:\/\/ceji.termedia.pl\/pdf-108591-129847","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ceji.termedia.pl\/pdf-108591-129847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:36:05Z","timestamp":1767947765000},"score":1,"resource":{"primary":{"URL":"https:\/\/ceji.termedia.pl\/Peripheral-blood-picture-and-aminotransferase-activity-in-children-with-newly-diagnosed,108591,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"alternative-id":["108591"],"URL":"https:\/\/doi.org\/10.5114\/ceji.2019.87063","relation":{},"ISSN":["1426-3912","1644-4124"],"issn-type":[{"value":"1426-3912","type":"print"},{"value":"1644-4124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]}}}